Phase 1 Renal Cell Carcinoma (RCC) trials recruiting now
All Renal Cell Carcinoma (RCC) trials, every phase
8
Phase 1 recruiting
Other phases for Renal Cell Carcinoma (RCC)
Phase 1 Renal Cell Carcinoma (RCC) trials
- A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
- A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
- A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
- Sapu003 in Advanced mTOR-sensitive Solid Tumors
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.